Skip to main content

and
Your search also matched 16 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis

Include preview-only content
  1. Article

    Open Access

    Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group

    Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes fo...

    Andrea Ruzzenente MD, PhD, Fabio Bagante MD, PhD in Annals of Surgical Oncology (2021)

  2. Article

    Correction to: Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

    In the original article Moritz Schmelzle’s last name is spelled wrong. It is correct as reflected here.

    Pim B. Olthof MD, PhD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2020)

  3. Article

    Open Access

    Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

    Preoperative portal vein embolization (PVE) is frequently used to improve future liver remnant volume (FLRV) and to reduce the risk of liver failure after major liver resection.

    Pim B. Olthof MD, PhD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2020)